Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation
CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies; however, its efficacy in solid tumors remains constrained. In this study, we demonstrate that Lentinan (LTN), an active polysaccharide derived from Lentinula edodes, potently enhances CAR-T cell function aga...
Saved in:
Main Authors: | Xiangyun Niu, Pengchao Zhang, Zhongming Liu, Yexiao Tang, Shu Xu, Xiaochun Wan, Zhiming Xu, Guizhong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1605488/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T therapy-based innovations in the enhancement of contemporary anti-tumor therapies
by: Wan-Ying Zhang, et al.
Published: (2025-07-01) -
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors
by: Mégane Jassin, et al.
Published: (2025-07-01) -
Assessment of the Adjuvant Effects of Lentinan on the Tuberculosis Subunit Vaccine BG
by: Shuai Zhou, et al.
Published: (2025-05-01) -
Resistance Mechanisms to BCMA Targeting Bispecific Antibodies and CAR T-Cell Therapies in Multiple Myeloma
by: Brandon Tedder, et al.
Published: (2025-07-01) -
Supplementation of lentinan improves lactation performance by altering ruminal microorganisms and metabolites in dairy cows
by: Lun Tan, et al.
Published: (2025-06-01)